Mandy A C Jongeneelen
Overview
Explore the profile of Mandy A C Jongeneelen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
262
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Geuijen C, Clijsters-van der Horst M, Cox F, Rood P, Throsby M, Jongeneelen M, et al.
J Immunol Methods
. 2005 Jul;
302(1-2):68-77.
PMID: 15992810
Application of antibody phage display to the identification of cell surface antigens with restricted expression patterns is often complicated by the inability to demonstrate specific binding to a certain cell...
2.
van den Brink E, Ter Meulen J, Cox F, Jongeneelen M, Thijsse A, Throsby M, et al.
J Virol
. 2005 Jan;
79(3):1635-44.
PMID: 15650189
Human monoclonal antibodies (MAbs) were selected from semisynthetic antibody phage display libraries by using whole irradiated severe acute respiratory syndrome (SARS) coronavirus (CoV) virions as target. We identified eight human...
3.
Geuijen C, Bijl N, Smit R, Cox F, Throsby M, Visser T, et al.
Eur J Cancer
. 2004 Dec;
41(1):178-87.
PMID: 15618003
Tumour-associated cell surface markers are potential targets for antibody-based therapies. We have obtained a panel of myeloid cell binding single chain variable fragments (scFv) by applying phage display selection on...
4.
Bakker A, van den Oudenrijn S, Bakker A, Feller N, van Meijer M, Bia J, et al.
Cancer Res
. 2004 Nov;
64(22):8443-50.
PMID: 15548716
Acute myeloid leukemia (AML) has a poor prognosis due to treatment-resistant relapses. A humanized anti-CD33 antibody (Mylotarg) showed a limited response rate in relapsed AML. To discover novel AML antibody...